Journal
Stem cell therapy cost by country (2026): sourced comparison
Stem cell therapy cost by country (2026): sourced comparison — Read the 2026 insight.
Open →Four approaches changing cell therapy in 2026
Four approaches changing cell therapy in 2026 — iPSC, allogeneic, organoids and AI compared by registered-study count.
Open →Which cell type is actually studied for which condition
Which cell type is actually studied for which condition — MSC, HSCT and exosomes compared across 26 conditions.
Open →Where cell-therapy trials actually are, and where they are still recruiting
Where cell-therapy trials actually are, and where they are still recruiting — Data briefing with sourced counts.
Open →Longevity molecules ranked by human evidence, not by marketing budget
Longevity molecules ranked by human evidence, not by marketing budget — Data briefing with sourced counts.
Open →Peptides in 2026: how much human evidence sits behind each one
Peptides in 2026: how much human evidence sits behind each one — Data briefing with sourced counts.
Open →Stem cell therapy cost in the EU — 2026 breakdown
Stem cell therapy cost in the EU — 2026 breakdown — Read the 2026 insight.
Open →Bulgaria vs Germany: stem cell cost compared
Bulgaria vs Germany: stem cell cost compared — Read the 2026 insight.
Open →Why US patients travel abroad for stem cell therapy
Why US patients travel abroad for stem cell therapy — Read the 2026 insight.
Open →Mesenchymal stem cells (MSCs), explained simply
Mesenchymal stem cells (MSCs), explained simply — Read the 2026 insight.
Open →Exosomes vs stem cells — what's the difference?
Exosomes vs stem cells — what's the difference? — Read the 2026 insight.
Open →Stem cell success rates: how to read the numbers
Stem cell success rates: how to read the numbers — Read the 2026 insight.
Open →Where the autism cell-therapy evidence stands in 2026
Where the autism cell-therapy evidence stands in 2026 — Read the 2026 insight.
Open →MS and regenerative medicine: the 2026 picture
MS and regenerative medicine: the 2026 picture — Read the 2026 insight.
Open →EU-based treatment, with published price observations — how it works
EU-based treatment, with published price observations — how it works — Read the 2026 insight.
Open →The travel cost most clinics never show you
The travel cost most clinics never show you — Read the 2026 insight.
Open →A Gulf patient's guide to cell therapy in the EU
A Gulf patient's guide to cell therapy in the EU — Read the 2026 insight.
Open →Safety first: questions to ask any clinic
Safety first: questions to ask any clinic — Read the 2026 insight.
Open →Cell-based anti-ageing: hype vs reality
Cell-based anti-ageing: hype vs reality — Read the 2026 insight.
Open →Cell therapy for knees and joints: cost & results
Cell therapy for knees and joints: cost & results — Read the 2026 insight.
Open →The diabetes cell-therapy frontier in 2026
The diabetes cell-therapy frontier in 2026 — Read the 2026 insight.
Open →Regenerative medicine for men's health, discreetly
Regenerative medicine for men's health, discreetly — Read the 2026 insight.
Open →Which cell type is right for your condition?
Which cell type is right for your condition? — Read the 2026 insight.
Open →How remote follow-up works after treatment abroad
How remote follow-up works after treatment abroad — Read the 2026 insight.
Open →Why we publish our prices when others hide them
Why we publish our prices when others hide them — Read the 2026 insight.
Open →A patient's first-visit diary: Sofia week
A patient's first-visit diary: Sofia week — Read the 2026 insight.
Open →Sofia rising: why Bulgaria's capital is booming
Sofia rising: why Bulgaria's capital is booming — Read the 2026 insight.
Open →Bulgaria's medical sector in 2026: faster, modern, EU-grade
Bulgaria's medical sector in 2026: faster, modern, EU-grade — Read the 2026 insight.
Open →The air that heals: Bulgaria's climate and recovery
The air that heals: Bulgaria's climate and recovery — Read the 2026 insight.
Open →800 mineral springs: Bulgaria's balneology advantage
800 mineral springs: Bulgaria's balneology advantage — Read the 2026 insight.
Open →Why 'stem cell abroad' searches tripled since 2023
Why 'stem cell abroad' searches tripled since 2023 — Read the 2026 insight.
Open →Orthopaedics: the fastest-growing cell-therapy demand
Orthopaedics: the fastest-growing cell-therapy demand — Read the 2026 insight.
Open →Neurology's regenerative frontier in 2026
Neurology's regenerative frontier in 2026 — Read the 2026 insight.
Open →From the Gulf to the EU: why families choose Bulgaria
From the Gulf to the EU: why families choose Bulgaria — Read the 2026 insight.
Open →Beating the wait: UK patients and regenerative medicine
Beating the wait: UK patients and regenerative medicine — Read the 2026 insight.
Open →The FDA gap: why Americans look abroad
The FDA gap: why Americans look abroad — Read the 2026 insight.
Open →From €30k to €6k: the German price-shock explained
From €30k to €6k: the German price-shock explained — Read the 2026 insight.
Open →China & East Asia patients: the EU option
China & East Asia patients: the EU option — Read the 2026 insight.
Open →Published price differences by condition: the data
Published price differences by condition: the data — Read the 2026 insight.
Open →The hidden cost of waiting for treatment
The hidden cost of waiting for treatment — Read the 2026 insight.
Open →Exosomes in 2026: where cell-free therapy is heading
Exosomes in 2026: where cell-free therapy is heading — Read the 2026 insight.
Open →The longevity boom and regenerative medicine
The longevity boom and regenerative medicine — Read the 2026 insight.
Open →Cell-based hair restoration: what works
Cell-based hair restoration: what works — Read the 2026 insight.
Open →Cell therapy vs knee replacement: the trade-offs
Cell therapy vs knee replacement: the trade-offs — Read the 2026 insight.
Open →The price-transparency movement in medical tourism
The price-transparency movement in medical tourism — Read the 2026 insight.
Open →How we vet every protocol before offering it
How we vet every protocol before offering it — Read the 2026 insight.
Open →What international patients tell us matters most
What international patients tell us matters most — Read the 2026 insight.
Open →Bulgaria in the EU since 2007: what it means for you
Bulgaria in the EU since 2007: what it means for you — Read the 2026 insight.
Open →The ideal recovery week in Bulgaria
The ideal recovery week in Bulgaria — Read the 2026 insight.
Open →Five myths about stem cell therapy abroad
Five myths about stem cell therapy abroad — Read the 2026 insight.
Open →12 questions to ask before booking anywhere
12 questions to ask before booking anywhere — Read the 2026 insight.
Open →